| First Author | Song Y | Year | 2020 |
| Journal | Mol Cancer | Volume | 19 |
| Issue | 1 | Pages | 2 |
| PubMed ID | 31901237 | Mgi Jnum | J:294162 |
| Mgi Id | MGI:6453316 | Doi | 10.1186/s12943-019-1124-x |
| Citation | Song Y, et al. (2020) The emerging role of SPOP protein in tumorigenesis and cancer therapy. Mol Cancer 19(1):2 |
| abstractText | The nuclear speckle-type pox virus and zinc finger (POZ) protein (SPOP), a representative substrate-recognition subunit of the cullin-RING E3 ligase, has been characterized to play a dual role in tumorigenesis and cancer progression. Numerous studies have determined that SPOP suppresses tumorigenesis in a variety of human malignancies such as prostate, lung, colon, gastric, and liver cancers. However, several studies revealed that SPOP exhibited oncogenic function in kidney cancer, suggesting that SPOP could exert its biological function in a cancer type-specific manner. The role of SPOP in thyroid, cervical, ovarian, bone and neurologic cancers has yet to be determined. In this review article, we describe the structure and regulation of SPOP in human cancer. Moreover, we highlight the critical role of SPOP in tumorigenesis based on three major categories: physiological evidence (animal models), pathological evidence (human cancer specimens) and biochemical evidence (downstream ubiquitin substrates). Furthermore, we note that SPOP could be a promising therapeutic target for cancer treatment. |
